Key statistics
As of last trade, Evotec SE (EVTX:GER) traded at 5.43, 10.81% above the 52 week low of 4.90 set on Dec 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.37 |
|---|---|
| High | 5.44 |
| Low | 5.36 |
| Bid | 5.43 |
| Offer | 5.45 |
| Previous close | 5.30 |
| Average volume | 647.56k |
|---|---|
| Shares outstanding | 177.88m |
| Free float | 160.14m |
| P/E (TTM) | -- |
| Market cap | 943.46m EUR |
| EPS (TTM) | -0.8955 EUR |
Data delayed at least 15 minutes, as of Mar 04 2026 08:14 GMT.
More ▼
- EQS-DD: Evotec SE: Dr. Cord Dohrmann, Disposal of 3653 shares (Sell-to-cover)
- EQS-DD: Evotec SE: Dr. Cord Dohrmann, Acquisition of 6760 shares due to vesting (Share Performance Plan 2017)
- EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
More ▼
